N-[(1S)-3-[3-[(4-bromophenyl)methyl]-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]-1-phenylpropyl]benzamide

C30H31BrN4O3 — CID 11433114

IUPACN-[(1S)-3-[3-[(4-bromophenyl)methyl]-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]-1-phenylpropyl]benzamide
SMILESO=C(N[C@@H](CCN1CCC2(CC1)NC(=O)N(Cc1ccc(Br)cc1)C2=O)c1ccccc1)c1ccccc1
InChIInChI=1S/C30H31BrN4O3/c31-25-13-11-22(12-14-25)21-35-28(37)30(33-29(35)38)16-19-34(20-17-30)18-15-26(23-7-3-1-4-8-23)32-27(36)24-9-5-2-6-10-24/h1-14,26H,15-21H2,(H,32,36)(H,33,38)/t26-/m0/s1
InChIKeyQJEDFXRVXPVEFY-SANMLTNESA-N
MW575.51 g/mol
LogP4.90
Rot. Bonds8

About N-[(1S)-3-[3-[(4-bromophenyl)methyl]-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]-1-phenylpropyl]benzamide

N-[(1S)-3-[3-[(4-bromophenyl)methyl]-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]-1-phenylpropyl]benzamide (PubChem CID 11433114) has the molecular formula C30H31BrN4O3 and a molecular weight of 575.51 g/mol. Its IUPAC name is N-[(1S)-3-[3-[(4-bromophenyl)methyl]-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]-1-phenylpropyl]benzamide.

Molecular Properties

Compound NameN-[(1S)-3-[3-[(4-bromophenyl)methyl]-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]-1-phenylpropyl]benzamide
PubChem CID11433114
Molecular FormulaC30H31BrN4O3
Molecular Weight575.51 g/mol
Exact Mass574.16
IUPAC NameN-[(1S)-3-[3-[(4-bromophenyl)methyl]-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]-1-phenylpropyl]benzamide
SMILESO=C(N[C@@H](CCN1CCC2(CC1)NC(=O)N(Cc1ccc(Br)cc1)C2=O)c1ccccc1)c1ccccc1
InChIInChI=1S/C30H31BrN4O3/c31-25-13-11-22(12-14-25)21-35-28(37)30(33-29(35)38)16-19-34(20-17-30)18-15-26(23-7-3-1-4-8-23)32-27(36)24-9-5-2-6-10-24/h1-14,26H,15-21H2,(H,32,36)(H,33,38)/t26-/m0/s1
InChIKeyQJEDFXRVXPVEFY-SANMLTNESA-N
XLogP4.90
TPSA81.75 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds8
Heavy Atoms38
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500575.51
LogP ≤ 54.90
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}

Analyze N-[(1S)-3-[3-[(4-bromophenyl)methyl]-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]-1-phenylpropyl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(1S)-3-[3-[(4-bromophenyl)methyl]-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]-1-phenylpropyl]benzamide?
The IUPAC name of N-[(1S)-3-[3-[(4-bromophenyl)methyl]-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]-1-phenylpropyl]benzamide (CID 11433114) is N-[(1S)-3-[3-[(4-bromophenyl)methyl]-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]-1-phenylpropyl]benzamide.
What is the SMILES notation for N-[(1S)-3-[3-[(4-bromophenyl)methyl]-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]-1-phenylpropyl]benzamide?
The canonical SMILES for N-[(1S)-3-[3-[(4-bromophenyl)methyl]-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]-1-phenylpropyl]benzamide is O=C(N[C@@H](CCN1CCC2(CC1)NC(=O)N(Cc1ccc(Br)cc1)C2=O)c1ccccc1)c1ccccc1.
What is the InChIKey of N-[(1S)-3-[3-[(4-bromophenyl)methyl]-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]-1-phenylpropyl]benzamide?
The InChIKey is QJEDFXRVXPVEFY-SANMLTNESA-N. The full InChI is InChI=1S/C30H31BrN4O3/c31-25-13-11-22(12-14-25)21-35-28(37)30(33-29(35)38)16-19-34(20-17-30)18-15-26(23-7-3-1-4-8-23)32-27(36)24-9-5-2-6-10-24/h1-14,26H,15-21H2,(H,32,36)(H,33,38)/t26-/m0/s1.
What are the key properties of N-[(1S)-3-[3-[(4-bromophenyl)methyl]-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]-1-phenylpropyl]benzamide?
N-[(1S)-3-[3-[(4-bromophenyl)methyl]-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]-1-phenylpropyl]benzamide has a molecular weight of 575.51 g/mol, XLogP of 4.90, 8 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1S)-3-[3-[(4-bromophenyl)methyl]-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]-1-phenylpropyl]benzamide is sourced from PubChem (CID 11433114), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).